Facebook
Twitter
LinkedIn
ForwardLambert-Eaton Myasthenic Syndrome (LEMS): Shaping Patient Journeys Through Eye Care (CME Symposium)
To claim your credit, please click Register/Take Course.
Saturday, October 19, 2024
6:00 PM – 6:30 PM CT Registration and Dinner
6:30 PM – 7:30 PM CT CME Symposium and Virtual Broadcast
Chicago Marriott Downtown Magnificent Mile
Salon 1, 7th Floor
540 Michigan Avenue
Chicago, Illinois
Target Audience
This educational activity is intended for ophthalmologists.
Learning Objectives
After completing this activity, participants will be better able to:
- Implement referrals on the basis of clinical features of Lambert-Eaton myasthenic syndrome
- Identify the appropriate diagnostic measures for Lambert-Eaton myasthenic syndrome
- Evaluate clinical trial data on treatment for Lambert-Eaton myasthenic syndrome
Faculty
 | Fiona Costello, MD, FRCPC (Co-Chair) Professor of Neurology Departments of Clinical Neurosciences and Surgery Cumming School of Medicine University of Calgary Clinician Scientist Hotchkiss Brain Institute Calgary, Canada |
 | Michael Lee, MD (Co-Chair) Professor Mackall-Scheie Endowed Chair Director of Neuro-Ophthalmology University of Minnesota Minneapolis, Minnesota |
Disclosure Policy
MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.
Faculty
Fiona Costello, MD, is an advisory board member of Horizon Therapeutics plc*; and is on the speakers bureau for Sanofi*.
Michael Lee, MD, is a consultant for Panbela Therapeutics, Inc; is an advisory board member of Amgen Inc*, is a contracted researcher for Invex Therapeutics*, and has stocks or stock options in Viridian Therapeutics, Inc*.
Peer Reviewer
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners, Managers, and Writers
MedEdicus planners and managers have no relevant commercial relationships to disclose.
* The financial relationship existed during the past 24 months but has now ended
Accreditation Statement
MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
MedEdicus LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
This continuing medical education activity is supported through an educational grant from Catalyst Pharmaceuticals, Inc.
Off-Label Discussion
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC or Catalyst Pharmaceuticals, Inc.
This CME activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. MedEdicus does not claim copyright to material included herein owned by third parties for which attribution or citation has been made. 330.1
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation